Aristolochic acid I induce DNA damage and cell cycle arrest in proximal tubule epithelium cell

李瑛,刘志红,郭啸华,苏健,陈朝红,周虹,黎磊石

DOI: https://doi.org/10.3969/j.issn.1006-298X.2004.01.002

2004-01-01

Abstract:Objective: Aristolochic acid I (AAI) has been proved responsible for the acellular tubulointerstitial damage in Chinese herb nephropathy and carcinogenic property in rodents. The mechanism has been seldom probed into so far. In this study, porcine proximal tubule epithelial cells (LLC-PK1) were used to examine AAI associated DNA damage and cell cycle arrest with respect to the involvement of P53 pathway activation. Methodology: LLC-PK1 cells were treated by adding AAI at different concentrations (80, 160, 320, 640 and 1280ng/ml) for 24 hours and a control group was set up. DNA damage and cell cycle arrest of LLC-PK1 cells were examined by single-cell gel electrophoresis (or comet assay) and flow cytometry (FCM). Expression of P53 protein in LLC-PK1 cells was detected with immunofluorescence staining and FCM. Results: DNA damage was not detected in control cells and LLC-PK1 cells treated with AAI (80ng/ml) by using comet assay. However, comet assay was positive ( with the appearance of a tail of damaged DNA migrating away from the nucleus) in LLC-PK1 cells exposed to AAI (160~1280ng/ml). A dose-dependant effect of AAI was detected by measuring the tail length, the ratio of tail length to full length, and the tail fluorescence intensity in these groups(P0.01). Necrosis and apoptosis were not found in LLC-PK1 cells treated with the range of AAI dosage (160~1280ng/ml). By using FCM, the percentage of cells in G2/M phase increased markedly and dose- dependantly in AAI treated (160-1280ng/ml) LLC-PK1 cells (P0.05 or P0.01). No difference was found between the treatment groups and the control group in the expression of P53 protein by detecting the intensity of immunofluorescence staining and mean fluorescence (P0.05 ). Conclusions: For cultured LLC-PK1 cells, AAI treatment can induce DNA damage and cell cycle arrest in G2/M phase in a dose-dependant manner. These effects of AAI in LLC-PK1 cells shed light on the mechanism of acellular and irreversible injury in tubulointerstitium of AAI nephropathy, and oncogenicity in urinary tract in AAI treated rodents.